Amgen Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 03:45PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director

This is Matthew Harrison. I'm one of the biotech analysts here at Morgan Stanley. Very pleased to have Amgen with me for the next session.

Quickly, before we get started, I need to read a brief disclaimer. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of...

(technical difficulty)

Please disconnect and -- separately.

For important disclosures, visit the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley representatives.

So I'm very pleased to have Bob Bradway, the CEO; Peter Griffith, the CFO; and Arvind Sood from IR. And Bob, I'm going to turn it over to you to make some opening comments, and then we'll get into Q&A.

Robert A. Bradway - Amgen Inc. - Chairman, CEO & President

Okay, Matthew. Well, first

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot